
|Articles|January 1, 2002
Risk scale optimizes nonmelanoma management
Created from 1,095 Mohs surgical cases, scale can predict likelihoodof subclinical spread of tumors
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Envudeucitinib Shows Durable Skin Clearance in Phase 3 Psoriasis Extension
2
The Emerging Role of Oral Peptide Therapeutics in Psoriasis and Beyond
3
Social Media Mythbusters: Hydrocolloid Pimple Patches
4
Common Mistakes in Managing Hair Loss and Pigmentary Disorders
5











